Development of a Benzoxazine-derived Inhibitor Targeting Epithelial-to-Mesenchymal Transition in Lung Cancer

Area of Science:

• Oncology
• Molecular Biology
• Cancer Research

Background:

• Epithelial-mesenchymal transition (EMT) is crucial for lung cancer metastasis.
• Targeting EMT is a potential therapeutic strategy for lung cancer.

Purpose of the Study:

• To investigate the EMT inhibitory effects of a new compound, 6,6'-(butylazanediyl) bis (methylene) bis (2,4-dimethylphenol) (2,4-diMBD).
• To evaluate the anti-metastatic potential of 2,4-diMBD in human lung cancer cells.

Main Methods:

• Cell viability, colony formation, and wound-healing assays were used to assess cell proliferation and migration.
• Immunofluorescence and real-time quantitative PCR were employed to examine protein and mRNA expression levels.

Main Results:

• 2,4-diMBD significantly inhibited lung cancer cell colony formation and migration.
• The compound reduced the expression of key EMT markers, including Snail, Slug, and ZEB, at both mRNA and protein levels.
• These findings indicate that 2,4-diMBD suppresses EMT in lung cancer cells.

Conclusions:

• 2,4-diMBD demonstrates anti-metastatic properties in lung cancer by inhibiting EMT.
• The compound represents a promising therapeutic candidate for lung cancer treatment.